anika research(anik) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : anika research(anik)

ANIK 9.880

+1.0%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (107)	3/5/1998 10:29:00 AM
From: George Loder	Read Replies (1) of 328

John, I read your message on the Yahoo about Anik. This market for Orthovisc is huge!!! Zimmer , a division of BMY has the product on the shelf and is awating FDA approval for distribution. This should occur in 4th Qtr of 98. Zimmer has a sales force of 500 highly trained Orthopaedic Reps to market this product to Orthopaedic Surgeons. The key is BMY and the amount of resources that they are going to commit to this 1 Billion dollar market. They will become the market leader. Totall value of market projected in US is 3 Billion dollars. Zimmers sales force has the know how and established relationships within th Orthopaedic community to drive this product to success. Look at Zimmer.com for additional information. Orthovisc will be approved and insurance companies will support its use in an effort to reduce costs associated with treating patients with OA. What do you think??? Regards shoota69

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next